FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
FLCN | Folliculin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
H3F3A | H3 histone, family 3A | Cancer-related genes
| | | | | Expressed in all |
H3F3B | H3 histone, family 3B (H3.3B) | Cancer-related genes
| | | | | Expressed in all |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KLF6 | Kruppel-like factor 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MEN1 | Multiple endocrine neoplasia I | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
MLH1 | MutL homolog 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MPL | Myeloproliferative leukemia virus oncogene | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Not detected |
MSH2 | MutS homolog 2 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MSH6 | MutS homolog 6 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MUTYH | MutY homolog | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NBN | Nibrin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NF2 | Neurofibromin 2 (merlin) | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
NFE2L2 | Nuclear factor, erythroid 2-like 2 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
NOTCH1 | Notch 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
PALB2 | Partner and localizer of BRCA2 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
PHF6 | PHD finger protein 6 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PMS2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
POT1 | Protection of telomeres 1 | Cancer-related genes
| | | | | Expressed in all |
PRDM1 | PR domain containing 1, with ZNF domain | Cancer-related genes Transcription factors
| | | | | Mixed |
PRKAR1A | Protein kinase, cAMP-dependent, regulatory, type I, alpha | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PTCH1 | Patched 1 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PTEN | Phosphatase and tensin homolog | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
RAD21 | RAD21 homolog (S. pombe) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
RB1 | Retinoblastoma 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
RPL10 | Ribosomal protein L10 | Cancer-related genes Disease related genes Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
RPL5 | Ribosomal protein L5 | Cancer-related genes Disease related genes Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
SDHB | Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
SETD2 | SET domain containing 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |